Years of research have showed that pulse oximeters yield less accurate readings for people with darker skin tones, and now ...
Artificial intelligence (AI) is transforming the health care landscape, from diagnostics to drug development and clinical trials. As AI ...
The FDA published its first draft guidance on the use of AI in the development of drugs and biological products ...
What Happened: The Food and Drug Administration (FDA) released new guidance regarding the registration and listing of ...
The U.S. FDA has released a new draft guidance for drugmakers to aid them in developing new treatments for obesity. The new ...
The FDA has set maximum levels for lead in packaged processed foods sold in jars, pouches, tubs or boxes. Here's what to know ...
The FDA’s guidance on AI in drug development points to potentially life-threatening consequences of the technology, ...
A Food and Drug Administration (FDA) draft guidance would require manufacturers of pulse oximeters to gather far more ...
In recent years, the FDA has amped up its supervision of accelerated approvals, including by requiring that confirmatory ...
After nearly a decade of machine learning innovations, the FDA has issued its first draft guidance on the use of AI in drug ...
The US FDA has issued guidance to limit lead levels in processed baby foods, aiming to reduce exposure by 20%-30%.
New draft guidelines would increase the number of people with darker skin who should be included in clinical trials of the ...